Skip directly to Accessibility Notice

How to Purchase

Sign-up to Receive
Our Latest Insights

BBH
VanEck Vectors Biotech ETF

Fund Description

VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

 
 

  • Fund Ticker

    BBH
  • Exchange

    NASDAQ
  • Commencement

    12/20/2011
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    Bank of New York Mellon
  • Index Ticker

    MVBBHTR
  • Index Rebalancing

    Quarterly

 
as of 06/26/19

  • 30-Day SEC Yield1

    0.29%
  • Total Net Assets

    $371.3M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.40%
  • Net Expense Ratio/TER2

    0.35%
  • Distribution Frequency

    Annual
  • Next Distribution Date

    12/20/2019

Portfolio Composition (%)
as of 06/26/19

  • % of Net Assets
  • Stocks

    100.05
  • Bonds

    0.00
  • Other

    0.00
  • Cash

    -0.05

Daily Holdings (%) as of 06/26/19 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
Amgen Inc
AMGN US
196,534
35,999,133 9.70
Gilead Sciences Inc
GILD US
432,483
28,837,966 7.77
Celgene Corp
CELG US
268,280
24,791,755 6.68
Allergan Plc
AGN US
146,066
23,954,824 6.45
Iqvia Holdings Inc
IQV US
127,659
19,867,570 5.35
Illumina Inc
ILMN US
52,660
18,766,444 5.05
Vertex Pharmaceuticals Inc
VRTX US
104,668
18,595,317 5.01
Biogen Inc
BIIB US
77,505
18,451,615 4.97
Incyte Corp
INCY US
212,052
18,158,013 4.89
Alexion Pharmaceuticals Inc
ALXN US
133,225
16,698,422 4.50
Exact Sciences Corp
EXAS US
143,156
16,146,565 4.35
Regeneron Pharmaceuticals Inc
REGN US
52,501
16,017,005 4.31
Biomarin Pharmaceutical Inc
BMRN US
185,881
15,418,829 4.15
Qiagen Nv
QGEN US
360,325
14,405,794 3.88
Beigene Ltd
BGNE US
114,434
14,265,342 3.84
Sarepta Therapeutics Inc
SRPT US
98,104
12,590,667 3.39
Charles River Laboratories Internationa
CRL US
74,424
10,199,065 2.75
Grifols Sa
GRFS US
446,956
8,894,424 2.40
Neurocrine Biosciences Inc
NBIX US
104,048
8,314,476 2.24
Alnylam Pharmaceuticals Inc
ALNY US
106,251
7,383,382 1.99
Ionis Pharmaceuticals Inc
IONS US
105,674
6,719,810 1.81
Seattle Genetics Inc
SGEN US
78,800
5,327,668 1.44
Nektar Therapeutics
NKTR US
141,910
4,724,184 1.27
United Therapeutics Corp
UTHR US
55,286
4,221,639 1.14
Bluebird Bio Inc
BLUE US
22,439
2,685,051 0.72
Other/Cash
--
--
-171,403 -0.05
These are not recommendations to buy or to sell any security. Securities and holdings may vary.